Differences in peripheral noradrenergic function among actively drinking and abstinent alcohol-dependent individuals

American Journal on Addictions

Volumn 13, Issue 3, 2004, Pages 225-235

  Patkar, Ashwin A ^a,e   Marsden, Charles A ^b   Naik, Prakash C ^c   Kendall, David A ^b   Gopalakrishnan, Raman ^d   Vergare, Michael J ^a   Weinstein, Stephen P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Lyndon Clinic   (United Kingdom)

^d ALBERT EINSTEIN MEDICAL CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DRINKING BEHAVIOR; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM; RACE; REMISSION;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE;

EID: 3042781955     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1080/10550490490459898     Document Type: Article

References (52)

1. Engel CK, Rudberg U. Age-dependent effects of ethanol on central monoamine synthesis in the male rat. Acta Pharmacol Toxicol. 1985;57:336-339.
2. Rabin RA, Wolfe BB, Dibner MK, et al. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther. 1980;213:491-496.
3. Thiele TE, Cubero I, van Dijk G, et al. Ethanol-induced c-fos expression in catecholamine- and neuropeptide Y-producing neurons in rat brainstem. Alcohol Clin Exp Res. 2000;24:802-809.
4. Hodge CW, Slawecki CJ, Aiken AS. Norepinephrine and serotonin receptors in the periventricular nucleus interactively modulate ethanol consumption. Alcohol Clin Exp Res. 1996;20:1669-1674.
5. Le AD, Kiianmaa K, Cunningham CL, et al. Neurobiological processes in alcohol addiction. Alcohol Clin Exp Res. 2001;25(5 Suppl ISBRA): 144S-151S.
6. Wang Y, Freund RK, Palmer MR. Potentiation of ethanol effects in cerebellum by activation of endogenous noradrenergic inputs. J Pharmacol Exp Ther. 1999;288:211-220.
7. Adell A, Myers RD. 5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of Harman. Neurochem Res. 1995;20:209-215.
8. Weinshenker D, Rust NC, Miller NS, et al. Ethanol-associated behaviors of mice lacking norepinephrine. J Neurosci. 2000;20:3157-3164.
9. Balldin J, Berggren U, Engel J, et al. Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal. Biol Psychiatry. 1992;31:712-719.
10. Linnoila M. Alcohol withdrawal and noradrenergic function. Ann Intern Med. 1987;107:875-889.
11. Nutt D, Glue P, Molyneux S, et al. Alpha-2-adrenoceptor function in alcohol withdrawal: a pilot study of the effects of i.v. clonidine in alcoholics and normals. Alcohol Clin Exp Res. 1988;12:14-18.
12. Smith AJ, Brent PJ, Henry DA, et al. Plasma noradrenaline, platelet α2-adrenoceptors, and functional scores during ethanol withdrawal. Alcohol Clin Exp Res. 1990;14:497-502.
13. Berggren U, Fahlke C, Norrby A, et al. Subsensitive alpha-2 adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence. Drug Alcohol Depend 2000;57:255-260.
14. Muller N, Hoehe M, Klein HE, et al. Endocrinological studies in alcoholics during withdrawal and after abstinence. Psychoneuroendocrinology. 1989;14:113-123.
15. Petrakis IL, Trevisan L, D'Souza C, et al. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls. Alcohol Clin Exp Res. 1999;23:1336-1341.
16. Krystal JH, Webb E, Cooney NL, et al. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbene effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry. 1996;153:83-92.
17. Howes LG, Reid JL. Changes in plasma free 3,4-dihydroxyphenylethylene glycol and noradrenaline levels after acute alcohol administration. Clin Sci. 1985;69:423-428.
18. Ireland M, Vandongen R, Davidson L, et al. Acute effects of moderate alcohol consumption on blood pressure and plasma catecholamines. Clin Sci. 1984;66:643-648.
19. McDougle CJ, Krystal JH, Price LH, et al. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbene. Psychopharmacology. 1995;118:127-135.
20. Carpenter KM, Hasin DS. Reliability and discriminant validity of the Type I/II and Type A/B alcoholic subtype classifications in untreated problem drinkers: a test of the Apollonian-Dionysian hypothesis. Drug Alcohol Depend. 2001;63:51-67.
21. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science. 1987;236:410-416.
22. Babor TF, Dolinsky ZS, Meyer MH, et al. Types of alcoholics: concurrent and predictive validity of some classification schemes. Br. J. Addic. 1992;87(10):1415-1431.
23. George DT, Benkelfat C, Rawlings RR, et al. Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry. 1997;154:81-87.
24. Tupala E, Kuidda JT, Hall H, et al. Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography. Neuroimage. 2001;14:87-94.
25. Von Knorring L, Oreland L, von Knorring AL. Personality traits and platelet MAO activity in alcohol and drug abusing teenage boys. Acta Psychiatry Scand. 1987;75:307-314.
26. Patkar AA, Naik P, Al-Chalabi T, et al. Platelet (3)H Imipramine binding in type I and type II alcoholism. Human Psychopharmacology. 1995;10:1-6.
27. Hansen AM, Garde AH, Skovgaard LT, et al. Seasonal and biological variation of urinary epinephrine, norepinephrine, and cortisol in healthy women. Clin Chim Acta. 2001;309:25-35.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
29. Stockwell T, Murphy D, Hodgson R. The severity of alcohol dependence questionnaire: its use, reliability and validity. British Journal of Addiction. 1983;78:145-156.
30. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analog scales: a critical review. Psychol Med. 1988;18:1007-1019.
31. Gilligan SB, Reich T, Cloninger RC. Alcohol related symptoms in heterogeneous families of hospitalized alcoholics. Alcohol Clin Exp Res. 1988;12:671-678.
32. Sullivan JL, Baeziger JC, Wagner DL, et al. Platelet MAO in subtypes of alcoholism. Biol. Psychiatry. 1990;27:911-922.
33. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-1907.
34. Soderstrom CA, Smith GS, Kufera JA, et al. The accuracy of the CAGE, the Brief Michigan Alcoholism Screening Test, and the Alcohol Use Disorders Identification Test in screening trauma center patients for alcoholism. J Trauma. 1997;43:962-969.
35. Foster CD, Taylor JY, Macdonald IA. The assay of the catecholamine content of small volumes of human plasma. In: Rollema H, Westerink BHC, Drijfhout WJ, eds. Monitoring Molecules in Neuroscience. Groningen: University Center for Pharmacy; 1991:173-175.
36. Fulford AJ, Marsden CA. Effect of isolation-rearing on noradrenaline release in rat hypothalamus and hippocampus in vitro. Brain Res. 1997;748:93-99.
37. Lapiz MD, Mateo Y, Durkin S, et al. Effects of central noradrenaline depletion by the selective neurotoxin DSp-4 on the behavior of the isolated rat in the elevated maze plus maze and water maze. Psychopharmacology (Berl). 2001;155:251-259.
38. Lowry O, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
39. Allemann PI. Markers for excessive alcohol use (screening). Ther Umsch. 2000;57:185-190.
40. Maki T, Toivonen L, Koskinen P, et al. Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol. 1998;82:317-322.
41. Fahlke C, Berggren U, Lundborg C, Balldin J. Psychopathology in alcohol withdrawal: relationship to alpha 2-adrenoceptor function. Alcohol Alcohol. 1999;34:750-759.
42. Ibsen H, Christensen MJ, Rasmussen S, et al. The influence of chronic high alcohol intake on blood pressure, plasma noradrenaline concentration and plasma renin concentration. Clin Sci. 1981;61:377-379.
43. Schneider F, Habel U, Wagner M, et al. Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry. 2001;158:1075-1083.
44. Patkar AA, Naik P, Zaman K, et al. Plasma serotonin (5-HT) levels and craving in alcohol dependent subjects during withdrawal [abstract]. Journal of Psychopharmacology. 1994; A34:133.
45. Roy A, Virkkunen M, Linnoila M. Reduced central turnover in a subgroup of alcoholics? Progresses in Neuropharmacology and Biological Psychiatry. 1987;11:173-177.
46. Parsian A, Suarez BK, Tabakoff B, et al. Monoamine oxidases and alcoholism: I. Studies in unrelated alcoholics and normal controls. Am J Med Genet. 1995;60:409-416.
47. Suarez BK, Hampe CL, Parsian A, et al. Monoamine oxidases and alcoholism: II. Studies in alcoholic families. Am J Med Genet. 1995;60:417-423.
48. Finlay JM, Zigmond MJ, Abercombie ED. Increased dopamine and norpepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 1995;64:619-628.
49. Stanford SC, Mikhail G, Salmon P, et al. Psychological stress does not affect plasma catecholamines in subjects with cardiovascular disorder. Pharmacol Biochem Behav. 1997;58:1167-1174.
50. Patel VA, Pohorecky LA. Interaction of stress and ethanol: effect on β-endorphin and catecholamines. Alcohol Clin Exp Res. 1988;12:785-788.
51. Linnoila M, Guthrie S, Lane EA, et al. Clinical studies on norepinephrine metabolism: how to interpret the numbers. Psychiatry Res. 1986;17:229-239.
52. Kopin IJ, Gordon EK, Jimerson DC, et al. Relationship between plasma and cerebrospinal fluid levels of 3- methoxy-4-hydroxy-phenyl glycol. Science. 1983;219:73-75.